Molecular Diagnostics Market By Type (Instruments, Software and Services, Reagents & Kits) By Technology (Hybridization, Polymerase Chain Reaction (PCR), Microarray, DNA Sequencing ) By Users(Hospitals, Laboratories).
Global Molecular Diagnostics Market was valued at USD 6.72 Billion in the year 2017. Global Molecular Diagnostics market is further expected to grow at a CAGR of 11.
60% from 2018 to reach USD 12.98 Billion by the year 2023. North America region holds the highest market share in 2017.
While Asia Pacific region is considered as the fastest growing market in the forecasted period. The U.S. is the major market in 2017 at country level and it is further anticipated to grow at a steady pace in the next 5 years.
Grifols (Spain), Roche Diagnostics (Switzerland), bioMérieux (France), Abbott Laboratories (U.S.) are some of the key manufacturers in the Global Molecular Diagnostics market with highest market share was held by Roche Diagnostics for better global presence both at production and at an operational level. Growing research and development expenditures to address changing demand of consumers, new product launches in recent years are some of the key market drivers.
Organic growth strategies adopted by most of Tier 1 and Tier 2 manufacturers in recent years is also providing comprehensive market opportunities for the various stakeholder.
Molecular diagnostics advancements
Growing infectious disease market
Lack of regulatory standards
Level of required financial investment & lack of technical expertise
Rising importance of diagnostics in improving healthcare quality
Development of emerging markets for Point of care testing.
Intense competition and reduced healthcare reimbursement
By type, the market is segmented as instruments, software and Services and Reagents & Kits. The Polymerase Chain Reaction (PCR) is likely to hold the top market share during the forecast period among all other technology segments.
The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity (disposable income). On the other hand, hospitals & clinical Laboratories for users is expected to grow at the highest CAGR of XXX during the year 2018-2023.
Software and Services
Reagents & Kits
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
- 1. Abbott Laboratories (U.S.)
- 2. Beckman Coulter Inc. (U.S.)
- 3. Biomérieux SA (France)
- 4. Grifols SA (Spain)
- 5. F. Hoffmann-La Roche AG (U.S.)
- 6. Becton, Dickinson and Company (U.S.)
- 7. Qiagen Netherlands (includes Digene) (Netherlands)
- 8. Danaher Corporation (Beckman Coulter) Lab 21 (US)
- 9. Agilent Technologies (Dako) (U.S)
- 10. Trinity Biotech (Ireland)
(A brief overview of another 13 companies is also provided)
Read Report Overview with Full TOC at goo.gl/ijeKK2
Category: Market Research Publishers and RetailersCompany about: Genesis Market Insights (GMI), is a subsidiary of Genesis Management & Market Research Pvt.Ltd. (GMMR) having a strong experience both in primary and secondary market research serving small to large scale enterprises across the globe. Established in 1993, GMMR has become a recommended brand for Market Research for various international and MNC Corporations with its strong data foundation. With its exhaustive research capabilities, strong analytics services and in-house data validation tools, ...